Infusion Therapy Market Size, Share and Growth Analysis - Forecast Trends and Outlook (2025-2034)

The global infusion therapy market was valued at USD 50.81 Billion in 2024 and is expected to grow at a CAGR of 6.80%, reaching USD 98.10 Billion by 2034 . The market growth is driven by the rising demand for advanced surgical equipment, coupled with large-scale hospital infrastructure investments and government funding initiatives across the region.

Key Trends and Insights

• By therapy type, the pain management segment accounted for the largest revenue share (37%) during the historical period.
• By end use, hospitals and clinics dominated the market with the highest revenue share of 43% in the historical period.
• North America emerged as the leading regional market, capturing a 56% revenue share in the historical period.

Market Size and Forecast

• Market Size (2024): USD 50.81 Billion
• Projected Market Size (2034): USD 98.10 Billion
• CAGR (2025-2034): 6.80%

Infusion Therapy Market Overview

The market is expanding rapidly due to the growing prevalence of chronic diseases, rising hospital admissions, and advancements in infusion technology. Increasing demand for home-based infusion services, coupled with innovations in infusion pumps and catheters, is reshaping care delivery. Favorable healthcare investments, expanding aging populations, and the shift toward minimally invasive treatments are further propelling market growth. Additionally, digital integration and telehealth capabilities are enhancing patient monitoring, ensuring better outcomes, and boosting overall market adoption. The market is expected to grow at a CAGR of 6.80% during the forecast period of 2025-2034 and attain a market value of USD 98.10 Billion by 2034 .

Infusion Therapy Market Growth Drivers

Technological Advancements Driving Market Growth

In January 2025, ICU Medical introduced its Plum Solo™ and Plum Duo™ precision IV pumps with FDA clearance. These devices offer enhanced dosing accuracy, improved safety features, and seamless integration into hospital systems. This innovation strengthens hospital adoption of advanced infusion devices, increases operational efficiency, and supports better patient outcomes. As healthcare facilities seek reliable and precise infusion solutions, such technological advancements directly drive the global infusion therapy market’s growth and adoption across both developed and emerging regions.

Infusion Therapy Market Trends

Major market trends include technological innovations, new product launches, and increasing adoption in hospitals and home-based care.

Adoption of Precision-focused Critical Care Systems to Boost Market Value

In August 2025, Terumo India launched Terufusion advanced infusion systems to enhance precision and safety in critical care. Hospitals are increasingly adopting these devices to improve clinical accuracy, reduce complications, and support complex patient management. The launch reflects the growing demand for technologically sophisticated infusion equipment capable of seamless integration into hospital workflows. Such innovations are driving market expansion by encouraging broader adoption across emerging and developed regions, increasing the need for advanced infusion solutions in high-acuity healthcare settings worldwide.

Specialized Infusion Devices to Expand Therapeutic Application, Bolstering Global Infusion Therapy Market Demand

In June 2025, Trisalus Life Sciences introduced Trinav FLX infusion, targeting oncology and chronic disease therapies. This specialized system allows hospitals and outpatient centers to safely administer advanced treatments, improving patient outcomes and operational efficiency. Its launch demonstrates the market’s shift toward diversified therapeutic applications, moving beyond traditional hospital use. Growing adoption of such devices by healthcare providers enhances access to complex treatments, drives sales of innovative infusion systems, and supports sustained global market growth by addressing the increasing demand for reliable, precise, and flexible infusion solutions.

Application of Long-lasting Infusion Therapies to Drive Market Demand

In May 2025, Johnson & Johnson reported that a single infusion of Carvykti (ciltacabtagene autoleucel) delivered durable remissions in patients with relapsed or refractory multiple myeloma. This achievement highlights the growing reliance on infusion therapies for chronic and complex conditions. Hospitals and specialty centers are increasingly investing in modern infusion devices capable of handling advanced therapies. As life-saving treatments continue to adopt infusion delivery methods, demand for reliable, high-performance infusion systems is expected to rise, further boosting the global infusion therapy market.

Regulatory Approvals to Accelerate Global Infusion Therapy Market Growth

In March 2025, Supernus received FDA approval for ONAPGOTM (apomorphine) infusion, facilitating broader clinical adoption. Regulatory support ensures faster integration of innovative infusion treatments, enabling healthcare providers to offer advanced therapies safely. Approval also signals strong industry investment in research and development, encouraging manufacturers to expand product portfolios and innovate. Enhanced access to approved infusion solutions improves patient outcomes and strengthens market penetration, ultimately driving sustained growth and adoption of infusion therapy solutions across hospitals, specialty centers, and home-care settings worldwide.

Infusion Therapy Market Share

Hospitals and Clinics to Lead the Market by End User

Hospitals and clinics emerged as the dominant end-use segment in the global infusion therapy market, accounting for the highest revenue share of 43% during the historical period. The preference for hospital-based infusion treatments is driven by the availability of skilled healthcare professionals, advanced infrastructure, and the need for continuous monitoring during therapy. Additionally, the increasing prevalence of chronic diseases and rising hospital admissions worldwide have reinforced demand for infusion services. This trend positions hospitals as the primary growth driver in the market.

Infusion Therapy Market Analysis by Region

North America led the market, capturing a substantial 56% revenue share during the historical period. The region’s dominance is supported by advanced healthcare infrastructure, high adoption of technologically sophisticated infusion devices, and strong investments in chronic disease management. Furthermore, increasing demand for home-based and outpatient infusion services, coupled with a well-established regulatory framework, has enhanced market penetration. The presence of leading market players and growing awareness of patient-centric therapies further consolidate North America’s position as the largest regional market.

Leading Players in the Infusion Therapy Market

The key features of the market report comprise patent analysis, funding and investment analysis, and strategic initiatives by the leading players. The major companies in the market are as follows:

B. Braun SE

Founded in 1839, B. Braun SE is headquartered in Melsungen, Germany. It’s a global leader in medical devices and pharmaceuticals. Its broad product portfolio includes infusion therapy (infusion pumps, solutions, IV access), surgery and orthopaedics, anaesthesia care, extracorporeal blood treatment, wound management, and hospital consumables. The company operates through divisions such as Hospital Care, Aesculap (surgical instruments), Avitum (dialysis), and the Outpatient Market, supplying hospitals, clinics, and home care globally.

Medtronic plc

Founded in 1949, Medtronic plc is a medical technology company headquartered in Dublin, Ireland, with operational headquarters in the United States. It develops and commercializes device-based therapies, including cardiovascular and vascular systems (pacemakers, defibrillators, stents), neuroscience (spinal stimulators, brain modulation), medical-surgical devices (surgical tools, robotics), and diabetes care. Medtronic serves hospitals, physicians, and integrated healthcare systems worldwide.

Becton, Dickinson and Company (BD)

Founded in 1897, Becton, Dickinson and Company (BD) is headquartered in Franklin Lakes, New Jersey, USA. BD is a major player in medical technology and devices, offering products across three divisions: BD Medical, BD Life Sciences, and BD Interventional. Its portfolio includes infusion systems (large volume and syringe pumps, infusion sets), drug delivery devices, diagnostics, and safety-engineered medical equipment. BD serves hospitals, outpatient care, and home health markets globally.

ICU Medical

Established in 1984, ICU Medical is headquartered in San Clemente, California, USA. It specializes in infusion therapy and related critical care products. Its offerings include IV smart pumps, ambulatory and large-volume infusion pumps, IV solutions and sets, needle-free connectors, closed system drug handling systems, anesthesia products, patient monitoring, and respiratory and temperature management systems. ICU supplies acute care hospitals, clinics, and alternative care sites.

Other key players in the market include Baxter AG, Terumo Medical Corporation, Fresenius Kabi, Cardinal Health, Mediprim GmbH, and Polymedicure.

Infusion Therapy Market Segmentation   

The market report offers a detailed analysis of the market based on the following segments:

Market Breakup by Product

• Infusion Pumps
• Ambulatory Infusion Pumps
• Stationary Infusion Pumps
• Syringe Infusion Pumps
• Disposable Pumps
• Large Volume Pumps
• Elastomeric Pumps
• Infusion Sets
• Accessories

Market Breakup by Indication

• Cancer
• Gastrointestinal Disorders
• Congestive Heart Failure
• Rheumatoid Arthritis
• Hemophilia
• Immune Deficiencies
• Others

Market Breakup by Therapy Type

• Antibiotic/Antiviral
• Anti-Coagulation
• Anti-Emetics
• Blood Component Stimulating Factor
• Chemotherapy
• Nutrition
• Hydration
• Pain Management
• Others

Market Breakup by End User

• Hospitals and Clinics
• Ambulatory Surgical Centers (ASCs)
• Homecare Settings
• Others

Market Breakup by Region

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East and Africa

Key Questions Answered in the Global Infusion Therapy Market

• What was the global infusion therapy market value in 2024?
• What is the global infusion therapy market forecast outlook for 2025-2034?
• What is the market breakup based on product?
• What is the market breakup based on the indication?
• What is the market breakup based on therapy type?
• What is the market breakup based on the end user?
• What are the major factors aiding the global infusion therapy market demand?
• How has the market performed so far, and how is it anticipated to perform in the coming years?
• What are the market's major drivers, opportunities, and restraints?
• What are the major global infusion therapy market trends?
• Which product will lead the market segment?
• Which indication will lead the market segment?
• Which therapy type will lead the market segment?
• Which end user will lead the market segment?
• Who are the key players involved in the global infusion therapy market?
• What are the current unmet needs and challenges in the market?

This product will be delivered within 3-5 business days.